The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...
The Brevard-based doctor and former congressman said: "The concern of many people is that big Pharma was behind this, which ...
Somehow Washington regards the industry, which has saved and improved tens of millions of lives, as a villain.
Both stocks should deliver excellent returns to investors patient enough to hold through volatility. Equity markets started ...
In addition to a continued focus on growing drug pipelines, and the increasing use of artificial intelligence (AI) and data ...
Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...
7h
Zacks Investment Research on MSNVertex Pharmaceuticals (VRTX) Rises But Trails Market: What Investors Should KnowVertex Pharmaceuticals (VRTX) closed the latest trading day at $512.52, indicating a +0.06% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 1.08%.
Among the 50 stocks in the Nifty index, 39 were trading in the green, while 11 were in the red. Shares of Vodafone Idea, ...
Amneal Pharmaceuticals (AMRX) is experiencing significant financial growth by focusing on making generic drugs more affordable and accessible—a ...
Mumbai-based Kilitch Drugs Ltd plans to enter biosimilars and oral solids, including diabetic and weight-loss tablets, and is ...
Driven by innovation, research, and a deep commitment to social responsibility, Pharmalat has grown from a small, family-run ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results